Form 8.3 - MEDICLINIC INTERNATIONAL PLC Amend

RNS Number : 9044J
Barclays PLC
15 December 2022
 

FORM 8.3

Amendment to Purchase






1.

KEY INFORMATION

(a)

Full name of discloser:


Barclays PLC.






(b)

Owner or controller of interest and short



positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

MEDICLINIC INTERNATIONAL PLC


relevant securities this form relates:

(d)

If an exempt fund manager connected with an



offeror/offeree, state this and specify identity of


offeror/offeree:



(e)

Date position held/dealing undertaken:

12 December 2022

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 



disclosures in respect of any other party to the offer?




2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

10p ordinary





(1)

Relevant securities owned






and/or controlled:








(2)

Cash-settled derivatives:















(3)

Stock-settled derivatives (including options)






and agreements to purchase/sell:















TOTAL:









(b)

Rights to subscribe for new securities (including directors and other executive

 

options)

 






Class of relevant security in relation to


which subscription right exists

Details, including nature of the rights


concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales





Class of relevant


Number of






securities




4.9530 GBP

4.9564 GBP

4.9520 GBP

4.9534 GBP

4.9549 GBP

4.9544 GBP

4.9580 GBP

4.9515 GBP

4.9537 GBP

4.9540 GBP

4.9550 GBP

4.9563 GBP

104.5000 ZAR

4.9584 GBP

4.9519 GBP

4.9529 GBP

4.9580 GBP

4.9527 GBP

4.9540 GBP

4.9589 GBP

4.9546 GBP

4.9507 GBP

4.9513 GBP

104.5000 ZAR









(b)

Cash-settled derivative transactions




Class of




Number of





reference

security






securities


4.9565 GBP

4.9519 GBP

4.9564 GBP

4.9540 GBP

4.9496 GBP

106.0326 ZAR

4.9512 GBP

105.9682 ZAR

4.9539 GBP

105.8522 ZAR

105.9714 ZAR

4.9509 GBP

4.9529 GBP

105.1539 ZAR

105.7796 ZAR

105.7203 ZAR

4.9505 GBP

4.9505 GBP

105.9521 ZAR

4.9513 GBP

104.4895 ZAR

4.9564 GBP

4.9546 GBP

4.9540 GBP

4.9540 GBP

4.9544 GBP

4.9514 GBP

106.0326 ZAR

106.1311 ZAR

105.9431 ZAR

4.9552 GBP

4.9545 GBP

106.0000 ZAR

105.8522 ZAR

106.0006 ZAR

105.1829 ZAR

4.9563 GBP

105.7796 ZAR

105.7203 ZAR

105.9839 ZAR

104.5000 ZAR









(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 




relevant




security


































(ii)

Exercising

 





Class of relevant

Product description

Number of

Exercise price per

















(d)

Other dealings (including subscribing for new securities)

 

Class of relevant











4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 


Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the person making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:


(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:


(i)  the voting rights of any relevant securities under any option; or


(ii)  the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:





(c)

Attachments

 





Is a Supplemental Form 8 (Open Positions) attached?

Date of disclosure:

15 Dec 2022




Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETKZMMZVKKGZZM

Companies

Barclays (BARC)
UK 100

Latest directors dealings